Andrographolide
Andrographolide is a diterpene lactone and bioactive phytochemical derived from Andrographis paniculata.
Andrographolide is a diterpene lactone and bioactive phytochemical derived from Andrographis paniculata. It is being investigated primarily in preclinical pharmacology, including studies of inflammation, cancer, pulmonary injury, enzyme inhibition, metabolism, and drug-delivery systems. Reported activities include modulation of inflammatory signaling and inhibition of acetylcholinesterase (AChE); in extracts of A. paniculata, andrographolide showed an AChE-inhibitory activity with an IC₅₀ of 97.1 μM.
Recent studies describe several context-dependent mechanisms. In an allergic-rhinitis mouse model, andrographolide alleviated nasal mucosal inflammation through inhibition of the IL-17/NF-κB pathway and downregulation of MUC5AC expression. In acute lung injury research, a neutrophil-targeted andrographolide liposome was developed to inhibit neutrophil extracellular trap formation (NETosis). Anticancer studies have examined andrographolide in combination with paclitaxel, cytarabine, vincristine, berbamine, or gemcitabine, with reported investigations involving apoptosis, reactive oxygen species, mitochondrial dysfunction, RRM2, and JAK/STAT3 signaling. Its lipophilicity and resulting low plasma concentrations have prompted investigation of nanoemulsions, liposomes, and other delivery systems. In mice, its hepatic metabolism has been associated with CYP2D22 and CYP2C29, including during analysis of Liandan Xiaoyan Formula metabolism in ulcerative-colitis models.
Where the papers sit
9 papers from the last 6 months study andrographolide directly · updated from PubMed 9 Nov 2026
Study type 0 clinical trials · 9 preclinical
Themes no clear themes
Those 9 do not share a common subject.
-
Nanoparticle delivery, anticancer combinations, inflammatory disease, tissue injury, and extract characterization occupy the shared terrain. Andrographolide is paired with paclitaxel, cytarabine, vincristine, or berbamine in cancer studies, while other reports test grapefruit vesicles, PLGA particles, or tumor-targeted chitosan. Additional work addresses ulcerative colitis, allergic rhinitis, glaucoma, acute lung injury, and acetylcholinesterase activity. No single mechanism, disease focus, or therapeutic direction unifies the cluster.
Papers
The 9 papers from the last 6 months that study andrographolide directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
No clear themes (9)
- Grapefruit-derived nanovesicles: a promising nanoplatform for enhancing the therapeutic efficacy of andrographolide against ulcerative colitis. Bioorganic chemistry · 1 Oct 2026 PMID 42822355
- Tumor-responsive hyalo-chitosan nanoparticles for targeted delivery of andrographolide in CD44+ breast cancer cells. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 27 Sept 2026 PMID 42801978
- Andrographolide-loaded PLGA nanoparticles protect retinal ganglion cells against experimental acute glaucomatous injury and attenuate mitochondrial dysfunction and retinal PANoptosis-related changes. International journal of pharmaceutics · 12 Sept 2026 PMID 42731713
- Synergistic anticancer potential of andrographolide and paclitaxel: a dose-reduction strategy to minimize toxicity and enhance therapeutic efficacy. Drug development and industrial pharmacy · 26 Jun 2026 PMID 42359982
- Metabolomics of Andrographis paniculata Burm. F. green extracts by an integrated LC-MS and NMR approach and evaluation of acetylcholinesterase and tyrosinase inhibitory activity of extracts and isolated compounds. Fitoterapia · 6 Jun 2026 PMID 42250615
- Targeting NETosis in the Lung: Respiratory Delivery of Neutrophil-Specific NEBP-Liposomes for Enhanced Therapy of Acute Lung Injury. Molecular pharmaceutics · 4 Jun 2026 PMID 42241382
- Low-dose Andrographolide Synergizes With Cytarabine or Vincristine in Plasma Cell Neoplasm Cell Lines. Anticancer research · 27 May 2026 PMID 42203354
- Synergistic effects of andrographolide and berbamine in glioblastoma: insights from proteomic and metabolomic pathway analysis. Bioorganic chemistry · 22 May 2026 PMID 42172796
- Andrographolide alleviates nasal mucosal inflammation in allergic rhinitis mice by inhibiting the IL-17/NF-κB pathway and downregulating MUC5AC expression. Journal of ethnopharmacology · 21 May 2026 PMID 42167662
By study type
Preclinical: animal, cell and lab studies (9)
- Grapefruit-derived nanovesicles: a promising nanoplatform for enhancing the therapeutic efficacy of andrographolide against ulcerative colitis. Bioorganic chemistry · 1 Oct 2026 PMID 42822355
- Tumor-responsive hyalo-chitosan nanoparticles for targeted delivery of andrographolide in CD44+ breast cancer cells. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 27 Sept 2026 PMID 42801978
- Andrographolide-loaded PLGA nanoparticles protect retinal ganglion cells against experimental acute glaucomatous injury and attenuate mitochondrial dysfunction and retinal PANoptosis-related changes. International journal of pharmaceutics · 12 Sept 2026 PMID 42731713
- Synergistic anticancer potential of andrographolide and paclitaxel: a dose-reduction strategy to minimize toxicity and enhance therapeutic efficacy. Drug development and industrial pharmacy · 26 Jun 2026 PMID 42359982
- Metabolomics of Andrographis paniculata Burm. F. green extracts by an integrated LC-MS and NMR approach and evaluation of acetylcholinesterase and tyrosinase inhibitory activity of extracts and isolated compounds. Fitoterapia · 6 Jun 2026 PMID 42250615
- Targeting NETosis in the Lung: Respiratory Delivery of Neutrophil-Specific NEBP-Liposomes for Enhanced Therapy of Acute Lung Injury. Molecular pharmaceutics · 4 Jun 2026 PMID 42241382
- Low-dose Andrographolide Synergizes With Cytarabine or Vincristine in Plasma Cell Neoplasm Cell Lines. Anticancer research · 27 May 2026 PMID 42203354
- Synergistic effects of andrographolide and berbamine in glioblastoma: insights from proteomic and metabolomic pathway analysis. Bioorganic chemistry · 22 May 2026 PMID 42172796
- Andrographolide alleviates nasal mucosal inflammation in allergic rhinitis mice by inhibiting the IL-17/NF-κB pathway and downregulating MUC5AC expression. Journal of ethnopharmacology · 21 May 2026 PMID 42167662
Written from 9 PubMed abstracts, each one listed by PMID above. Published: 2026-10-29. Drafted by language models from published abstracts; not medical advice.